Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Return on Sales (2021 - 2025)

Historic Return on Sales for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 0.03%.

  • Rxo's Return on Sales fell 200.0% to 0.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.02%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.02% for FY2025, which is 500.0% up from last year.
  • Per Rxo's latest filing, its Return on Sales stood at 0.03% for Q4 2025, which was down 200.0% from 0.01% recorded in Q3 2025.
  • Over the past 5 years, Rxo's Return on Sales peaked at 0.04% during Q2 2022, and registered a low of 0.23% during Q3 2024.
  • In the last 5 years, Rxo's Return on Sales had a median value of 0.0% in 2023 and averaged 0.01%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -2300bps in 2024, then soared by 2200bps in 2025.
  • Quarter analysis of 5 years shows Rxo's Return on Sales stood at 0.03% in 2021, then crashed by -111bps to 0.0% in 2022, then skyrocketed by 157bps to 0.0% in 2023, then crashed by -833bps to 0.01% in 2024, then plummeted by -109bps to 0.03% in 2025.
  • Its Return on Sales stands at 0.03% for Q4 2025, versus 0.01% for Q3 2025 and 0.01% for Q2 2025.